Literature DB >> 18704691

Exercise in prevention and management of cancer.

Robert U Newton1, Daniel A Galvão.   

Abstract

OPINION STATEMENT: Regular and vigorous physical exercise has been scientifically established as providing strong preventative medicine against cancer with the potential to reduce incidence by 40%. The effect is strongest for breast and colorectal cancer; however, evidence is accumulating for the protective influence on prostate cancer, although predominantly for more advanced disease and in older men. Following cancer diagnosis, exercise prescription can have very positive benefits for improving surgical outcomes, reducing symptom experience, managing side effects of radiation and chemotherapy, improving psychological health, maintaining physical function, and reducing fat gain and muscle and bone loss. There is now irrefutable evidence from large prospective studies that regular exercise postdiagnosis will actually increase survivorship by 50%-60% with the strongest evidence currently for breast and colorectal cancers. In our work with prostate cancer patients, we have found that exercise can limit or even reverse some of the androgen deprivation therapy (ADT) adverse effects by increasing muscle mass, functional performance, and cardiorespiratory fitness without elevating testosterone levels. Hormone therapies for breast and prostate cancer can result in alarmingly increased risk of cardiovascular disease, obesity, type 2 diabetes, osteoporosis, and sarcopenia. Increasingly, patients are questioning the benefit of some cancer treatments as the risk of morbidity and mortality from other chronic diseases begins to outweigh the initial cancer diagnosis. Over three decades of research in exercise science and many hundreds of RCTs demonstrate the efficacy of appropriate physical activity for preventing and managing these secondary diseases. Based on this evidence it is now clear to us that exercise is a critical adjuvant therapy in the management of many cancers and will greatly enhance the therapeutic effects of traditional radiation and pharmaceutical treatments by increasing tolerance, reducing side effects, and lowering risk of chronic diseases, even those not aggravated by cancer treatment. While patients and their clinicians deal with their cancer, other chronic disease mechanisms continue unabated. Anxiety, depression, poor nutritional choices, and a counterproductive rest strategy will accelerate these processes, while a well-designed exercise program adhered to by the patient and supported by the medical and exercise professionals will effectively control and even reverse these diseases and disabilities. In the wide range of cancer populations that we work with, both young and old and with curative and palliative intent, our overwhelming experience is that exercise is first well tolerated, and benefits the patientpsychologically and physically. While some of our patients are on individual, home-based programs, we find that small group exercise sessions with close supervision by Exercise Physiologists (EP) provides a more motivating setting and the social interaction is critical for adherence and retention as well as greater psychological benefits such as reduced anxiety and depression and enhanced social connectedness. While managing many hundreds of cancer patients over the last 6 years, our clinic has not experienced any instances of the exercise hindering patient recovery or treatment purpose, nor have any significant injuries occurred. However, it is critical that the exercise prescription and management be tailored to the individual patient and that they are monitored by appropriately trained and professionally accredited exercise specialists. For those patients at low exercise risk and without significant musculoskeletal issues, community-based physical activity is of excellent benefit where the emphasis should be on adherence, affordability, convenience, and enjoyment.

Entities:  

Mesh:

Year:  2008        PMID: 18704691     DOI: 10.1007/s11864-008-0065-1

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  44 in total

Review 1.  Review of exercise intervention studies in cancer patients.

Authors:  Daniel A Galvão; Robert U Newton
Journal:  J Clin Oncol       Date:  2005-02-01       Impact factor: 44.544

2.  Physical activity and risk of colorectal cancer in Japanese men and women: the Japan Public Health Center-based prospective study.

Authors:  Kyung-Jae Lee; Manami Inoue; Tetsuya Otani; Motoki Iwasaki; Shizuka Sasazuki; Shoichiro Tsugane
Journal:  Cancer Causes Control       Date:  2007-01-06       Impact factor: 2.506

3.  A prospective study of physical activity and incident and fatal prostate cancer.

Authors:  Edward L Giovannucci; Yan Liu; Michael F Leitzmann; Meir J Stampfer; Walter C Willett
Journal:  Arch Intern Med       Date:  2005-05-09

4.  Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.

Authors:  Milena Braga-Basaria; Adrian S Dobs; Denis C Muller; Michael A Carducci; Majnu John; Josephine Egan; Shehzad Basaria
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

5.  A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults.

Authors:  Nalin A Singh; Theodora M Stavrinos; Yvonne Scarbek; Garry Galambos; Cas Liber; Maria A Fiatarone Singh
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-06       Impact factor: 6.053

6.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

Authors:  William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman
Journal:  Med Sci Sports Exerc       Date:  2007-08       Impact factor: 5.411

7.  A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

Authors:  Phyllis M Windsor; Kathleen F Nicol; Joan Potter
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  The global burden of chronic diseases: overcoming impediments to prevention and control.

Authors:  Derek Yach; Corinna Hawkes; C Linn Gould; Karen J Hofman
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

9.  Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions.

Authors:  Lee W Jones; Carolyn J Peddle; Neil D Eves; Mark J Haykowsky; Kerry S Courneya; John R Mackey; Anil A Joy; Vikaash Kumar; Timothy W Winton; Tony Reiman
Journal:  Cancer       Date:  2007-08-01       Impact factor: 6.860

10.  Endocrine and immune responses to resistance training in prostate cancer patients.

Authors:  D A Galvão; K Nosaka; D R Taaffe; J Peake; N Spry; K Suzuki; K Yamaya; M R McGuigan; L J Kristjanson; R U Newton
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-07-17       Impact factor: 5.554

View more
  42 in total

1.  Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan.

Authors:  Lisa K Sprod; Michelle C Janelsins; Oxana G Palesh; Jennifer K Carroll; Charles E Heckler; Luke J Peppone; Supriya G Mohile; Gary R Morrow; Karen M Mustian
Journal:  J Cancer Surviv       Date:  2011-12-10       Impact factor: 4.442

2.  A Feasibility Study Related To Inactive Cancer Survivors Compared with Non-Cancer Controls during Aerobic Exercise Training.

Authors:  Scott N Drum; Riggs J Klika; Susan D Carter; Lisa K Sprod; Lars Donath
Journal:  J Sports Sci Med       Date:  2016-12-01       Impact factor: 2.988

Review 3.  [Secondary and tertiary prevention of urological tumors].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 4.  Clinical exercise interventions in prostate cancer patients--a systematic review of randomized controlled trials.

Authors:  Freerk T Baumann; Eva M Zopf; Wilhelm Bloch
Journal:  Support Care Cancer       Date:  2011-10-12       Impact factor: 3.603

Review 5.  Effects of living at higher altitudes on mortality: a narrative review.

Authors:  Martin Burtscher
Journal:  Aging Dis       Date:  2013-12-05       Impact factor: 6.745

Review 6.  p53, aerobic metabolism, and cancer.

Authors:  Cory U Lago; Ho Joong Sung; Wenzhe Ma; Ping-yuan Wang; Paul M Hwang
Journal:  Antioxid Redox Signal       Date:  2011-04-14       Impact factor: 8.401

7.  Health-related quality of life and pelvic floor dysfunction in advanced-stage ovarian cancer survivors: associations with objective activity behaviors and physiological characteristics.

Authors:  Christelle Schofield; Robert U Newton; Paul A Cohen; Daniel A Galvão; Joanne A McVeigh; Ganendra R Mohan; Jason Tan; Stuart G Salfinger; Leon M Straker; Carolyn J Peddle-McIntyre
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

Review 8.  Enhancing active surveillance of prostate cancer: the potential of exercise medicine.

Authors:  Daniel A Galvão; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Renea Taylor; Gail P Risbridger; Mark Frydenberg; Michelle Hill; Suzanne K Chambers; Phillip Stricker; Tom Shannon; Dickon Hayne; Eva Zopf; Robert U Newton
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

Review 9.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

10.  Devising the optimal preclinical oncology curriculum for undergraduate medical students in the United States.

Authors:  Nicholas J DeNunzio; Lija Joseph; Roxane Handal; Ankit Agarwal; Divya Ahuja; Ariel E Hirsch
Journal:  J Cancer Educ       Date:  2013-06       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.